Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
2 followers
Eikon Therapeutics
4 followers
Gilead Sciences
208 followers
Regeneron
179 followers
Illumina
90 followers
Agilent Technologies
98 followers
Verily Life Sciences
49 followers
Alexion Pharmaceuticals
56 followers